Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: A translational study

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Gordillo Moscoso, Antonio ^a   Ruiz, Emilio ^a   Carnero, Manuel ^b   Reguillo, Fernando ^b   Rodriguez, Enrique ^b   Tejerina, Teresa ^a   Redondo, Santiago ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

COX 2; Diabetes mellitus; Human arteries; Lipid profile

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; CYCLOOXYGENASE 2; FIBRINOGEN; GELATINASE B; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTACYCLIN; PROSTAGLANDIN E2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CORONARY VESSELS; CYCLOOXYGENASE 2; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TRIGLYCERIDES; TUNICA MEDIA;

EID: 84877002648     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-62     Document Type: Article

References (27)

1. Diabetes trends in the U.S.: 1990-1998. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS, Diabetes Care 2000 23 1278 1283 10.2337/diacare.23.9.1278 10977060
2. The continuing epidemics of obesity and diabetes in the United States. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP, JAMA 2001 2000 286 1195 2000
3. American Heart Association, 2004 Heart disease and stroke statistical update Dallas: American Heart Association 2004
4. Non-insulin dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Revean GM, Metabolism 1987 36 1 8 3807791
5. Lipids glucose tolerance and vascular disease. The Framingham Study. Wilson PW, Kannel WB, Anderson, Monogr Atheroscler 1985 13 1 11 4088271
6. Plasma lipids and diabetes mellitus in an adult community. Barret-Connor E, Grundy SM, Am J Epidemio. 1982 115 657 663 (Pubitemid 12074271)
7. Duff memorial lecture atherogenesis in diabetes. Bierman EL, George L, Arterioscler Thromb 1992 12 647 656 10.1161/01.ATV.12.6.647 1591228
8. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. Ridker PM, Rifai ON, Rose L, Buring JE, Cook NR, N Engl J Med 2002 347 1557 1565 10.1056/NEJMoa021993 12432042 (Pubitemid 35315836)
9. Prostaglandin H synthase and vascular function. Davidge ST, Circ Res 2000 89 650 660 (Pubitemid 34627064)
10. COX-2 upregulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Guo Z, Su W, Allen S, Daugherty A, Smart E, Gong MC, Cardiovascular Res 2005 67 723 735 10.1016/j.cardiores.2005.04.008 (Pubitemid 41033368)
11. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A, Bagi Z, Circ Res 2006 99 12 e17 10.1161/01.RES.0000241051.83067.62 16917094 (Pubitemid 44337812)
12. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis. Redondo S, Ruiz E, Gordillo-Moscoso A, Navarro-Dorado J, Ramajo M, Rodríguez E, Reguillo F, Carnero M, Casado M, Tejerina T, Diabetologia 2011 54 190 199 10.1007/s00125-010-1947-x 20957341
13. Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high Bcl-2 expression. Ruiz E, Gordillo-Moscoso A, Padilla E, Redondo S, Rodríguez E, Reguillo F, Briones AM, van Breemen C, Okon E, Tejerina T, Diabetes 2006 55 1243 1251 10.2337/db05-0949 16644678 (Pubitemid 44195360)
14. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli-Gatti C, Joch H, Volpe M, Luscher TF, Circulation 2003 107 1017 1023 10.1161/01.CIR.0000051367.92927.07 12600916 (Pubitemid 36258726)
15. Diagnosis and classification of Diabetes Mellitus. American Diabetes Association, Diabetes Care 2005 28 37 S42 15618111
16. Molecular mechanisms of high-glucose-induced cyclooxygenase-2 expression in monocytes. Shanmugan N, Gonzalo I, Natarajan R, Diabetes 2004 53 795 802 10.2337/diabetes.53.3.795 14988266 (Pubitemid 38270651)
17. High glucose enhances IL-1β-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells. Lee SH, Woo HY, Baik EJ, Moon CH, Life Sci 2000 68 57 67 10.1016/S0024-3205(00)00920-6 11132246
18. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR, Curr Mol Med 2006 6 501 514 10.2174/156652406778018680 16918371
19. Adipose tissue: a regulator of inflammation. Juge-Aubry CE, Henrichot E, Meier CA, Best Pract Res Clin Endocrinol Metab 2005 19 547 66 10.1016/j.beem.2005.07.009 16311216 (Pubitemid 41823815)
20. Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Hara S, Morishita R, Tone Y, Yokoyama C, Inoue H, Kaneda Y, Ogihara T, Tanabe T, Biochem Biophys Res 2005 216 862 867
21. Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids. Willis AL, Smith DL, Vigo C, Prog Lipid Res 1986 85 2800 2804
22. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoids network. Hajjar DP, Pomerantz KB, FASEB J 1992 6 2933 2941 1644257
23. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibit platelet aggregation. Moncada S, Gryglewski R, Bunting S, Vane JR, Nature 1976 263 663 665 10.1038/263663a0 802670
24. Alteration in prostacyclin and prostaglandin E2 production: correlation with changes in human aortic atherosclerotic disease. Rolland PH, Jouve R, Pellegrin E, Merceir C, Serradimigni A, Arteriosclerosis 1984 4 70 478 10.1161/01.ATV.4.1.70 6581776
25. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation and cellular differentiation. Welgus HG, Campbell EJ, Curry JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg I, J Clin Invest 1990 86 1496 1502 10.1172/JCI114867 2173721 (Pubitemid 20372596)
26. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Zhou MH, Prostaglandins Other Lipid Media 2007 82 119 127 10.1016/j. prostaglandins.2006.05.005 (Pubitemid 44911071)
27. Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Nie H, Wu JL, Zhang M, Xu J, Zou MH, Diabetes 2006 55 3133 3141 10.2337/db06-0505 17065353 (Pubitemid 44923653)